I wrote to the CFF regarding this topic and this is the e-mail the I received.
<div class="FTQUOTE"><begin quote>Text</end quote></div>Dear Ms. Morgan -
Thank you for your note. We appreciate your concerns about the use of B. cepacia in agriculture.
If you will note, the article from the CDC web site that you sent to us is dated 1998. We initially were alerted to this problem by concerned parents such as yourself back in the late 1990s. We aggressively pursued it with EPA and the help of Congress. As a result, we were able to get the US Environmental Protection Agency to change its standards on the approval of the use of B. cepacia as a biopesticide. The one product that had been approved has since been taken off the market by the manufacturer. And no new products have been approved to my knowledge.
I've pasted information about the CFF's work on this issue below and attached a letter from EPA in 2003 showing the success we had in removing the product from the market.
Burkholderia cepacia and the EPA
The CF Foundation's undaunted efforts to restrict the use of Burkholderia cepacia (B. cepacia) in the environment has yielded victory on two fronts. B. cepacia can be very harmful and difficult to treat in people with CF. First, the use of B. cepacia as a biopesticide has been halted. As of May 13, 2003, the Environmental Protection Agency (EPA) cancelled the registrations of all pesticide products containing B. cepacia, and it is now a violation of EPA law to distribute or sell any of these cancelled pesticides.
Second, the EPA finalized its rule on new uses of B. cepacia for bioremediation or environmental clean up. Now, companies must notify the EPA 90 days in advance of manufacturing, importing, or processing any new item that contains B. cepacia. With this rule, the EPA can evaluate the company's intended new use of B. cepacia and, if necessary, prohibit or limit that use before it occurs.
Please let us know if you have additional questions.
Take care and good luck to you and your child.
Suzanne
Suzanne R. Pattee, J.D.
Vice President of Regulatory and Patient Affairs
Cystic Fibrosis Foundation
6931 Arlington Road
Bethesda, Maryland 20814
Phone: 301-907-2548
Fax: 301-951-6378
Cell: 703-304-4109
E-mail: spattee@cff.org
Web: www.cff.org